BioCentury
ARTICLE | Company News

Lidak cancer, enabling technology, infectious diseases news

October 12, 1998 7:00 AM UTC

LDAKA will change its name to Avanir Pharmaceuticals subject to approval by a majority of the company's shareholders. Avanir reserved the ticker symbol AVNR on NASDAQ. ...